{
    "organizations": [],
    "uuid": "7169192f4e001afcf3c01c5d792bda5588fbed96",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/shire-ma-servier/shire-to-sell-oncology-business-to-servier-for-2-4-bln-idUSL8N1RT0ZA",
    "ord_in_thread": 0,
    "title": "Shire to sell oncology business to Servier for $2.4 bln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "LONDON, April 16 (Reuters) - Shire, the London-listed pharmaceutical company which specialises in rare diseases, said on Monday it was selling its oncology business to French drug maker Servier for $2.4 billion.\nShire, which is a possible bid target for Japanâ€™s largest drugmaker Takeda Pharmaceutical, said it would consider returning the proceeds of the sale to shareholders through a buyback. (Reporting by Sarah Young; editing by Kate Holton)\n ",
    "published": "2018-04-16T14:51:00.000+03:00",
    "crawled": "2018-04-17T12:28:27.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "london",
        "april",
        "reuters",
        "shire",
        "pharmaceutical",
        "company",
        "specialises",
        "rare",
        "disease",
        "said",
        "monday",
        "selling",
        "oncology",
        "business",
        "french",
        "drug",
        "maker",
        "servier",
        "billion",
        "shire",
        "possible",
        "bid",
        "target",
        "japan",
        "largest",
        "drugmaker",
        "takeda",
        "pharmaceutical",
        "said",
        "would",
        "consider",
        "returning",
        "proceeds",
        "sale",
        "shareholder",
        "buyback",
        "reporting",
        "sarah",
        "young",
        "editing",
        "kate",
        "holton"
    ]
}